18 Seth Klarman Theravance Biopharma Trades
The first Theravance Biopharma trade was made in Q2 2014. Since then Seth Klarman bought shares eight more times and sold shares on nine occasions. The investor completely sold their stake between Q1 2022 and Q3 2024.
Avg closing price
Price range
Sold -4.2M shares
Q3 2024
Avg closing price
$8.65
Price range
$7.66
-
$10.25
Sold 36.3% shares (-2.39M shares)
Q2 2024
Avg closing price
$9.03
Price range
$8.29
-
$9.92
Sold 11.1% shares (-825k shares)
Q1 2024
Avg closing price
$9.27
Price range
$8.22
-
$11.59
Sold 28.8% shares (-3M shares)
Q2 2023
Avg closing price
$11.04
Price range
$10.16
-
$11.92
Sold 8.8% shares (-1M shares)
Q1 2023
Avg closing price
$10.57
Price range
$9.87
-
$11.44
Sold 14.9% shares (-2M shares)
Q4 2022
Avg closing price
$10.51
Price range
$9.65
-
$11.34
Sold 1.6% shares (-224k shares)
Q2 2022
Avg closing price
$9.21
Price range
$8.41
-
$10.34
Sold 0.1% shares (-16.8k shares)
Q1 2022
Avg closing price
$9.80
Price range
$8.33
-
$12.96
Increased shares by 37.8% (+3.75M shares)
Q3 2021
Avg closing price
$11.19
Price range
$6.77
-
$14.41
Increased shares by 13.5% (+1.18M shares)
Q2 2021
Avg closing price
$18.78
Price range
$14.52
-
$22.46
Sold 6.2% shares (-574k shares)
Q3 2020
Avg closing price
$18.73
Price range
$14.78
-
$22.49
Increased shares by 0.4% (+35.2k shares)
Q3 2017
Avg closing price
$32.70
Price range
$23.88
-
$42.56
Increased shares by 26.2% (+1.92M shares)
Q4 2016
Avg closing price
$31.02
Price range
$24.57
-
$38.58
Increased shares by 13.1% (+850k shares)
Q2 2016
Avg closing price
$21.59
Price range
$17.45
-
$24.20
Increased shares by 1.3% (+81k shares)
Q1 2016
Avg closing price
$16.36
Price range
$13.35
-
$18.80
Increased shares by 0.8% (+53.5k shares)
Q2 2015
Avg closing price
$15.51
Price range
$12.57
-
$18.63
Increased shares by 5.0% (+305k shares)
Q1 2015
Avg closing price
$18.33
Price range
$14.70
-
$21.73
New holding (+6.06M shares)
Q2 2014
Avg closing price
$30.10
Price range
$23.51
-
$34.87
